MYCi361
MYCi361 is an inhibitor of MYC (binding to MYC with Kd of 3.2 μM) . MYCi361 is a small-molecule MYC inhibitors that inhibits the viability of MYC-dependent cancer cells including prostate cancer (MycCaP, LNCaP, and PC3), leukemia (MV4-11), lymphoma (HL-60 and P493-6), and neuroblastoma (SK-N-B2) with low-micromolar IC50 values.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
594.86
Molecular Formula
C26H16ClF9N2O2
Notes
Research use only, not for human use.
Receptor
MYC
CAS Number
2289690-31-7
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6250717-01 0.1 mL
CD88 (CD88 Antigen, Anaphylatoxin Receptor, C5a Anaphylatoxin Chemotactic Receptor, C5aR, C5a-R, C5a Ligand, C5R1) (HRP)
Ask
View Details MBS6250717-02 5x 0.1 mL
CD88 (CD88 Antigen, Anaphylatoxin Receptor, C5a Anaphylatoxin Chemotactic Receptor, C5aR, C5a-R, C5a Ligand, C5R1) (HRP)
Ask
View Details